EUR 15.45
(1.31%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 40.13 Million EUR | -7.34% |
2022 | 43.31 Million EUR | 22.41% |
2021 | 35.38 Million EUR | 32.27% |
2020 | 26.75 Million EUR | 0.31% |
2019 | 26.66 Million EUR | 17.45% |
2018 | 22.7 Million EUR | -10.03% |
2017 | 25.23 Million EUR | 165.27% |
2016 | 9.51 Million EUR | 1.18% |
2015 | 9.4 Million EUR | -30.67% |
2014 | 13.56 Million EUR | 118.53% |
2013 | 6.2 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 37.94 Million EUR | -5.46% |
2024 Q2 | 39.57 Million EUR | 4.3% |
2023 Q4 | 40.13 Million EUR | -10.08% |
2023 FY | 40.13 Million EUR | -7.34% |
2023 Q2 | 43.35 Million EUR | 1.36% |
2023 Q3 | 44.63 Million EUR | 2.96% |
2023 Q1 | 42.77 Million EUR | -1.26% |
2022 Q1 | 39.29 Million EUR | 11.06% |
2022 FY | 43.31 Million EUR | 22.41% |
2022 Q4 | 43.31 Million EUR | -1.33% |
2022 Q3 | 43.9 Million EUR | -2.79% |
2022 Q2 | 45.16 Million EUR | 14.92% |
2021 Q2 | 32.54 Million EUR | 27.94% |
2021 Q1 | 25.43 Million EUR | -4.91% |
2021 Q3 | 31.97 Million EUR | -1.75% |
2021 Q4 | 35.38 Million EUR | 10.66% |
2021 FY | 35.38 Million EUR | 32.27% |
2020 Q2 | 29.3 Million EUR | 18.73% |
2020 Q1 | 24.68 Million EUR | -7.44% |
2020 Q4 | 26.75 Million EUR | -4.97% |
2020 Q3 | 28.15 Million EUR | -3.94% |
2020 FY | 26.75 Million EUR | 0.31% |
2019 Q2 | 31.75 Million EUR | 19.57% |
2019 FY | 26.66 Million EUR | 17.45% |
2019 Q4 | 26.66 Million EUR | -11.34% |
2019 Q3 | 30.08 Million EUR | -5.26% |
2019 Q1 | 26.55 Million EUR | 16.95% |
2018 Q1 | 26.56 Million EUR | 5.28% |
2018 Q2 | 27.84 Million EUR | 4.81% |
2018 FY | 22.7 Million EUR | -10.03% |
2018 Q4 | 22.7 Million EUR | -13.06% |
2018 Q3 | 26.11 Million EUR | -6.22% |
2017 Q1 | 9.98 Million EUR | 4.94% |
2017 Q2 | 15.03 Million EUR | 50.62% |
2017 Q3 | 12.38 Million EUR | -17.65% |
2017 Q4 | 25.23 Million EUR | 103.8% |
2017 FY | 25.23 Million EUR | 165.27% |
2016 Q1 | 9.78 Million EUR | 4.06% |
2016 FY | 9.51 Million EUR | 1.18% |
2016 Q2 | 11.64 Million EUR | 19.0% |
2016 Q4 | 9.51 Million EUR | 0.9% |
2016 Q3 | 9.42 Million EUR | -19.02% |
2015 Q3 | 11.89 Million EUR | -10.87% |
2015 Q2 | 13.35 Million EUR | 8.36% |
2015 Q4 | 9.4 Million EUR | -20.98% |
2015 Q1 | 12.32 Million EUR | -9.15% |
2015 FY | 9.4 Million EUR | -30.67% |
2014 Q3 | 12.21 Million EUR | 32.77% |
2014 FY | 13.56 Million EUR | 118.53% |
2014 Q4 | 13.56 Million EUR | 11.07% |
2014 Q1 | 6.2 Million EUR | -0.06% |
2014 Q2 | 9.19 Million EUR | 48.28% |
2013 Q2 | 11.45 Million EUR | 47.82% |
2013 Q3 | 8.45 Million EUR | -26.2% |
2013 Q4 | 6.2 Million EUR | -26.61% |
2013 FY | 6.2 Million EUR | 0.0% |
2013 Q1 | 7.75 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Cellularline S.p.A. | 98.74 Million EUR | 59.353% |
Indel B S.p.A. | 94.77 Million EUR | 57.647% |